Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Impax

- PMLiVE

GSK trial throws everything at COPD

Tests combination of fluticasone furoate, umeclidinium and vilanterol

- PMLiVE

GSK wins approval for skin cancer drug Mekinist in EU

Will compete with Roche’s Zelboraf and BMS’ Yervoy in melanoma

- PMLiVE

GSK takes anti-inflammatory drug into phase III as heart therapy

Studies losmapimod’s potential in acute coronary syndrome

- PMLiVE

Prosensa says it could file muscular dystrophy drug this year

Drisapersen still shows promise despite GSK’s decision to terminate collaboration

- PMLiVE

GSK and Bayer strike new biotech cancer deals

Agreements with Orion and Adaptimmune aimed at strengthening their respective oncology pipelines

- PMLiVE

GSK plans to sell off older products

Invites bids for mature brands as part of move to focus on growth areas

- PMLiVE

UK authorities open investigation into GSK

Serious Fraud Office launches probe after international corruption allegations

- PMLiVE

Japanese product news in brief

Home launch for Astellas' Xtandi, GSK files COPD drug for approval and more

- PMLiVE

GSK and Genmab’s Arzerra fails lymphoma trial

Cancer drug unable to beat Roche's MabThera in late-stage study

- PMLiVE

Second darapladib failure disappoints GSK

Drug unable to demonstrate effectiveness in acute coronary syndrome

China flag thumb

China targets UK exec in GSK corruption probe

Former GSK China manager Mark Reilly said to have ordered sales team to bribe doctors

- PMLiVE

GSK clear to launch COPD hope Anoro in Europe

Strengthens respiratory platform ahead of patent expiry for Advair/Seretide

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links